Advocacy & Practice Updates — Advocacy & Practice
ASRS-Led Advocacy Success: CMS to Exclude Retina Specialists From 2023 Diabetes Cost Measure
On October 27, ASRS received confirmation from CMS that beginning for the 2023 performance year, it will apply the same attribution methodology to both groups and individuals reporting MIPS for the diabetes episode-based cost measure, which will ensure that retina specialists in private practice will not be scored on the measure.
ASRS and our allies in the ophthalmic community have been advocating to CMS to make this change to prevent retina specialists who report MIPS as a group from receiving penalties for treating diabetic Medicare beneficiaries who have ocular co-morbidities.
At this time, CMS has not agreed to modify 2022 MIPS scores for retina specialists and other ophthalmologists who have been scored on this measure. However, ASRS, along with AAO and ASCRS, will be meeting with CMS to discuss the issue further and will push to have the change applied retroactively to 2022 scores.
Thank you to all the practices that contacted ASRS and submitted targeted reviews to CMS. Your efforts helped make a difference on this issue!
If you have questions, or need assistance, please contact Allison Madson, vice president of health policy at allison.madson@asrs.org.
ASRS and our allies in the ophthalmic community have been advocating to CMS to make this change to prevent retina specialists who report MIPS as a group from receiving penalties for treating diabetic Medicare beneficiaries who have ocular co-morbidities.
At this time, CMS has not agreed to modify 2022 MIPS scores for retina specialists and other ophthalmologists who have been scored on this measure. However, ASRS, along with AAO and ASCRS, will be meeting with CMS to discuss the issue further and will push to have the change applied retroactively to 2022 scores.
Thank you to all the practices that contacted ASRS and submitted targeted reviews to CMS. Your efforts helped make a difference on this issue!
If you have questions, or need assistance, please contact Allison Madson, vice president of health policy at allison.madson@asrs.org.
(Published 9.27.23)